Amgen Short Term: above its upper Bollinger band
May 8, 2024 09:14
Amgen (AMGN.US)
-2.21-0.70%
the upside prevails as long as 282.3 is support.
Our pivot point stands at 282.3.
Our preference: the upside prevails as long as 282.3 is support.
Alternative scenario: the downside breakout of 282.3 would call for 262.7 and 251.4.
Comment: the RSI is above its neutrality area at 50. The MACD is positive and above its signal line. The configuration is positive. Moreover, the stock is trading above both its 20 and 50 day moving average (respectively at 273.6475 and 275.5808). Finally, Amgen has crossed above its upper daily Bollinger band (297.31).
Supports and resistances:
373.4 **
361.2 *
349.3 **
337.1
299.48 (USD-last)
289.8
282.3 **
262.7 *
251.4 **
Our preference: the upside prevails as long as 282.3 is support.
Alternative scenario: the downside breakout of 282.3 would call for 262.7 and 251.4.
Comment: the RSI is above its neutrality area at 50. The MACD is positive and above its signal line. The configuration is positive. Moreover, the stock is trading above both its 20 and 50 day moving average (respectively at 273.6475 and 275.5808). Finally, Amgen has crossed above its upper daily Bollinger band (297.31).
Supports and resistances:
373.4 **
361.2 *
349.3 **
337.1
299.48 (USD-last)
289.8
282.3 **
262.7 *
251.4 **
Disclaimer: References, analysis and trading strategies are provided by the third-party provider, Trading Central, and the point of view is based on the independent assessment and judgment of the analyst, without considering the investment objectives and financial situation of the investors. All strategic opinions do not constitute investment advice or recommendations and are for references only. Our company also does not guarantee the accuracy of the strategic views and does not take any responsibility for the negative results caused by the trading strategies.
